144 related articles for article (PubMed ID: 30025813)
1. Inhibition of microRNA-505 suppressed MPP+ -induced cytotoxicity of SHSY5Y cells in an in vitro Parkinson's disease model.
Zhu J; Wang S; Liang Y; Xu X
Eur J Pharmacol; 2018 Sep; 835():11-18. PubMed ID: 30025813
[TBL] [Abstract][Full Text] [Related]
2. MiR-212 Attenuates MPP⁺-Induced Neuronal Damage by Targeting KLF4 in SH-SY5Y Cells.
Song Y; Liu Y; Chen X
Yonsei Med J; 2018 May; 59(3):416-424. PubMed ID: 29611404
[TBL] [Abstract][Full Text] [Related]
3. Down-Regulation of ID2-AS1 Alleviates the Neuronal Injury Induced by 1-Methy1-4-Phenylpyridinium in Human Neuroblastoma Cell Line SH-SY5Y Cells Through Regulating miR-199a-5p/IFNAR1/JAK2/STAT1 Axis.
Xu F; Wang H; Tian J; Xu H
Neurochem Res; 2021 Aug; 46(8):2192-2203. PubMed ID: 34050453
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of miR-34a, miR-141, and miR-9 in MPP+-treated differentiated PC12 cells as a model of Parkinson's disease.
Rostamian Delavar M; Baghi M; Safaeinejad Z; Kiani-Esfahani A; Ghaedi K; Nasr-Esfahani MH
Gene; 2018 Jul; 662():54-65. PubMed ID: 29631008
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA-p21 regulates MPP
Ding XM; Zhao LJ; Qiao HY; Wu SL; Wang XH
Chem Biol Interact; 2019 Jul; 307():73-81. PubMed ID: 31004593
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-599 regulates the development of Parkinson's disease through mediating LRRK2 expression.
Wu Q; Xi DZ; Wang YH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):724-731. PubMed ID: 30720180
[TBL] [Abstract][Full Text] [Related]
7. Pramipexole Inhibits MPP
Deng C; Zhu J; Yuan J; Xiang Y; Dai L
Neurochem Res; 2020 Feb; 45(2):268-277. PubMed ID: 31811458
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA NORAD functions as a microRNA-204-5p sponge to repress the progression of Parkinson's disease in vitro by increasing the solute carrier family 5 member 3 expression.
Zhou S; Zhang D; Guo J; Chen Z; Chen Y; Zhang J
IUBMB Life; 2020 Sep; 72(9):2045-2055. PubMed ID: 32687247
[TBL] [Abstract][Full Text] [Related]
9. Upregulated lncRNA small nucleolar RNA host gene 1 promotes 1-methyl-4-phenylpyridinium ion-induced cytotoxicity and reactive oxygen species production through miR-15b-5p/GSK3β axis in human dopaminergic SH-SY5Y cells.
Xie N; Qi J; Li S; Deng J; Chen Y; Lian Y
J Cell Biochem; 2019 Apr; 120(4):5790-5801. PubMed ID: 30302821
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA NORAD regulates MPP+-induced Parkinson's disease model cells.
Song Q; Geng Y; Li Y; Wang L; Qin J
J Chem Neuroanat; 2019 Nov; 101():101668. PubMed ID: 31421205
[TBL] [Abstract][Full Text] [Related]
12. MiR-29a efficiently suppresses the generation of reactive oxygen species and α-synuclein in a cellular model of Parkinson's disease by potentially targeting GSK-3β.
Yang YL; Lin TK; Huang YH
Eur J Pharmacol; 2024 Jul; 974():176615. PubMed ID: 38685306
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-135b alleviates MPP
Zeng R; Luo DX; Li HP; Zhang QS; Lei SS; Chen JH
J Clin Neurosci; 2019 Jul; 65():125-133. PubMed ID: 31036506
[TBL] [Abstract][Full Text] [Related]
14. LncRNA XIST sponges miR-199a-3p to modulate the Sp1/LRRK2 signal pathway to accelerate Parkinson's disease progression.
Zhou Q; Zhang MM; Liu M; Tan ZG; Qin QL; Jiang YG
Aging (Albany NY); 2021 Jan; 13(3):4115-4137. PubMed ID: 33494069
[No Abstract] [Full Text] [Related]
15. miR-494-3p modulates the progression of in vitro and in vivo Parkinson's disease models by targeting SIRT3.
Geng L; Zhang T; Liu W; Chen Y
Neurosci Lett; 2018 May; 675():23-30. PubMed ID: 29567426
[TBL] [Abstract][Full Text] [Related]
16. LncRNA SNHG15 mediates 1-methyl-4-phenylpyridinium (MPP
Li J; Sun Z; Song L
Neurol Res; 2023 Feb; 45(2):181-190. PubMed ID: 36384413
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MIAT Inhibits MPP
Xu X; Zhang Y; Kang Y; Liu S; Wang Y; Wang Y; Wang L
Neurochem Res; 2021 Dec; 46(12):3365-3374. PubMed ID: 34514556
[TBL] [Abstract][Full Text] [Related]
18. Astrocyte-Derived Exosomal microRNA miR-200a-3p Prevents MPP
Shakespear N; Ogura M; Yamaki J; Homma Y
Neurochem Res; 2020 May; 45(5):1020-1033. PubMed ID: 32016794
[TBL] [Abstract][Full Text] [Related]
19. circSAMD4A participates in the apoptosis and autophagy of dopaminergic neurons via the miR‑29c‑3p‑mediated AMPK/mTOR pathway in Parkinson's disease.
Wang W; Lv R; Zhang J; Liu Y
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34080649
[TBL] [Abstract][Full Text] [Related]
20. MiR-29a inhibits MPP + - Induced cell death and inflammation in Parkinson's disease model in vitro by potential targeting of MAVS.
Yang YL; Lin TK; Huang YH
Eur J Pharmacol; 2022 Nov; 934():175302. PubMed ID: 36174668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
